Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,434,877 papers from all fields of science
Search
Sign In
Create Free Account
QS 21
Known as:
Stimulon QS-21 Adjuvant
, QS-21 Adjuvant
, QS21
Expand
A purified, natural saponin isolated from the soapbark tree Quillaja saponaria Molina with potential immunoadjuvant activity. When co-administered…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Cytotoxic T-Lymphocytes
GM2-KLH vaccine/QS21
KSA glycoprotein/QS21
KSA-KLH conjugate vaccine/QS21
Expand
Broader (2)
Immunologic Adjuvants
Saponins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Aqueous extract of Calamus rotang as a novel immunoadjuvant enhances both humoral and cell mediated immune response
A. Gupta
,
A. C. Shaikh
,
S. Chaphalkar
2016
Corpus ID: 73541757
Introduction: Search for new adjuvants for human vaccines has become an expanding field of research in the last thirty years for…
Expand
2015
2015
Adjuvant Systems containing monophosphoryl lipid A and S-21 induce strong humoral and cellular immune responses against epatitis B surface antigen which persist for at least 4 years after accination
eert Leroux-Roelsa
,
Pascale Van Belleb
,
+6 authors
arcelle Van Mechelenb
2015
Corpus ID: 44237762
Background: Recombinant hepatitis B surface antigen (HBsAg) was used as a model antigen to evaluate persistence of cellular and…
Expand
2004
2004
A novel potassium deficiency-induced stimulon in Anabaena torulosa
Hree
,
Umar
2004
Corpus ID: 28713080
Potassium deficiency enhanced the synthesis of fifteen proteins in the nitrogen-fixing cyanobacterium Anabaena torulosa and of…
Expand
2004
2004
ANTICANCER AND IMMUNOSTIMULATORY EFFECTS OF NUCLEOPROTEIN FRACTION OF BACILLUS SUBTILIS 7025 CULTURE MEDIUM FILTRATE
V. Shlyakhovenko
,
S. Olishevsky
,
+6 authors
Ñ. Ë. Ðûáàëêî
2004
Corpus ID: 44748575
Recent advances in our understanding of tumor immunology and the immune response in general are allowing the development of new…
Expand
2004
2004
DNA vaccination may open up a new avenue for treatment of Alzheimer disease.
S. Tsuji
Archives of Neurology
2004
Corpus ID: 19205047
ACCUMULATION OF AMYLOID- (A 40�42 ) peptides that are generated by proteolytic processing of amyloid precursor protein is widely…
Expand
2004
2004
Communicated by : LJ Old Ex vivo detectable activation of MelanA-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA
D. Liénard
,
D. Rimoldi
,
+13 authors
D. Speiser
2004
Corpus ID: 39764794
The purpose of this study was to test melanoma vaccines consisting of peptides and immunological adjuvants for optimal…
Expand
2003
2003
Fully S ynthetic C arbohydrate-Bas ed V accines i n B iochemically Relapsed P rostate C ancer: C linical T rial R esults With - N -Acetylgalactosa mine- O -Serine/Threonin e Conjugate V accine
S. Slovin
,
G. Ragupathi
,
+8 authors
H. Scher
2003
Corpus ID: 78643974
Purpose: We report the synthesis of a mucin-related O-linked glycopeptide, -N-acetylgalactosamine-O-serine/ threonine (Tn), which…
Expand
2002
2002
Vaccination with CD 20 peptides induces a biologically active , specific immune response in mice
Wendy K. Roberts
,
P. Livingston
,
D. Agus
,
J. Pinilla-Ibarz
,
A. Zelenetz
,
D. Scheinberg
2002
Corpus ID: 32971483
CD20 is a 33-kD B-cell antigen that is expressed from the early pre–B-cell stage of development and is lost on differentiation of…
Expand
2002
2002
Thomsen-Friedenreich cluster -KLH conjugate vaccine plus the immunological adjuvant QS21 in prostate cancer
S. Slovin
,
G. Ragupathi
,
+10 authors
H. Scher
2002
Corpus ID: 78794942
Review
1997
Review
1997
The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma: prognosis versus efficacy, toxicity and costs
A. Eggermont
Melanoma research
1997
Corpus ID: 13336624
Various adjuvant therapy trials in high risk melanoma are at present ongoing in the world. Interferon-α (IFN-α) and ganglio-side…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE